Table 6 Risk of individual outcome according to treatment with statin in the nested case–control study

Statin

0.73 [0.59–0.89], P = 0.002

0.81 [0.63–1.03], P = 0.083

0.76 [0.58–0.99], P = 0.039

1.12 [0.62–2.00], P = 0.710

0.56 [0.38–0.82], P = 0.003

Cumulative statin exposure

  < 1 year

1 (Ref)

1 (Ref)

1 (Ref)

1 (Ref)

1 (Ref)

 1–3 year(s)

0.73 [0.57–0.94], P = 0.015

0.80 [0.60–1.07], P = 0.131

0.82 [0.60–1.12], P = 0.219

0.69 [0.33–1.48], P = 0.345

0.58 [0.35–0.95], P = 0.031

  > 3 years

0.60 [0.47–0.77], P < 0.001

0.66 [0.49–0.88], P = 0.005

0.63 [0.45–0.87], P = 0.005

0.81 [0.41–1.58], P = 0.531

0.46 [0.29–0.74], P < 0.001